This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Biomedical Center Munich / LMU Munich
bmc-lmu.bsky.social
did:plc:p33n3g3aksmvbhhyllxevs2l
Axel Imhof & his team are playing a key role in the new CDKspot research project. It aims to develop new cyclin-dependent kinase (CDK) inhibitors that could be used as applicable therapeutics against 🧠 #cancer and #viral #infections.
➡️ https://www.med.lmu.de/bmc/en/news/latest-news/news-overview/news/cdkspot-new-therapeutics-for-the-treatment-of-brain-tumours-and-viral-infections.html
#Proteomics #CDKinhibitors
2025-02-18T09:33:15.149Z